LENZ Therapeutics
Stock Forecast, Prediction & Price Target
LENZ Therapeutics Financial Estimates
LENZ Therapeutics Revenue Estimates
LENZ Therapeutics EBITDA Estimates
LENZ Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $15M 0% | $0 -100% | Avg: $6.73M Low: $2.73M High: $9.04M avg. 0% | Avg: $51.36M Low: $16.54M High: $82.00M avg. 662.94% | Avg: $143.2M Low: $46.12M High: $228.61M avg. 178.79% | Avg: $215.7M Low: $69.47M High: $344.36M avg. 50.62% |
Net Income
% change YoY
| $-70.76M N/A | $-101.05M -42.80% | $-124.65M -23.35% | Avg: $-19.52M Low: $-23.12M High: $-17.24M avg. 84.33% | Avg: $-18.92M Low: $-33.60M High: $-2.24M avg. 3.06% | Avg: $5.98M Low: $710.59K High: $10.62M avg. 131.62% | Avg: $19.62M Low: $2.32M High: $34.85M avg. 227.89% |
EBITDA
% change YoY
| $-59.70M N/A | $-97.29M -62.94% | $-122.24M -25.64% | Avg: $4.03M Low: $1.64M High: $5.42M avg. 103.30% | Avg: $30.81M Low: $9.92M High: $49.20M avg. 662.94% | Avg: $85.92M Low: $27.67M High: $137.17M avg. 178.79% | Avg: $129.42M Low: $41.68M High: $206.61M avg. 50.62% |
EPS
% change YoY
| -$2.85 N/A | -$4.3 -50.87% | -$15.3 -255.81% | Avg: -$2.4 Low: -$2.84 High: -$2.12 avg. 84.33% | Avg: -$2.32 Low: -$4.13 High: -$0.28 avg. 3.06% | Avg: $0.74 Low: $0.09 High: $1.3 avg. 131.62% | Avg: $2.41 Low: $0.29 High: $4.28 avg. 227.89% |
Operating Expenses
% change YoY
| $59.70M N/A | $97.29M 62.94% | $70.70M -27.32% | Avg: $8.33M Low: $3.38M High: $11.20M avg. -88.21% | Avg: $63.59M Low: $20.48M High: $101.52M avg. 662.94% | Avg: $177.28M Low: $57.09M High: $283.03M avg. 178.79% | Avg: $267.04M Low: $86.00M High: $426.33M avg. 50.62% |
FAQ
What is LENZ Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 111.72% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -23.12M, average is -19.52M and high is -17.24M.
What is LENZ Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 223.09% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $2.73M, average is $6.73M and high is $9.04M.
What is LENZ Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 111.72% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.84, average is -$2.4 and high is $-2.11.